Roxadustat for Patients with Posttransplant Anemia: A Narrative Review
Background: Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) are novel oral agents used for renal anemia treatment. Roxadustat, a first-in-class HIF-PHI used for treating anemia in chronic kidney disease patients, has been approved in China, Japan, South Korea, Chile, and Europe. Ro...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Karger Publishers
2023-11-01
|
| Col·lecció: | Kidney Diseases |
| Matèries: | |
| Accés en línia: | https://beta.karger.com/Article/FullText/535071 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|